ZA200708753B - Biocompatible polymer compounds for medicinal formulations - Google Patents

Biocompatible polymer compounds for medicinal formulations

Info

Publication number
ZA200708753B
ZA200708753B ZA200708753A ZA200708753A ZA200708753B ZA 200708753 B ZA200708753 B ZA 200708753B ZA 200708753 A ZA200708753 A ZA 200708753A ZA 200708753 A ZA200708753 A ZA 200708753A ZA 200708753 B ZA200708753 B ZA 200708753B
Authority
ZA
South Africa
Prior art keywords
biocompatible polymer
polymer compounds
medicinal formulations
medicinal
formulations
Prior art date
Application number
ZA200708753A
Other languages
English (en)
Inventor
John T Capecchi
James S Stefely
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of ZA200708753B publication Critical patent/ZA200708753B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200708753A 2005-03-14 2007-10-12 Biocompatible polymer compounds for medicinal formulations ZA200708753B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66137005P 2005-03-14 2005-03-14

Publications (1)

Publication Number Publication Date
ZA200708753B true ZA200708753B (en) 2008-10-29

Family

ID=36992328

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708753A ZA200708753B (en) 2005-03-14 2007-10-12 Biocompatible polymer compounds for medicinal formulations

Country Status (11)

Country Link
US (1) US20080112894A1 (ja)
EP (1) EP1868610A4 (ja)
JP (1) JP2008533149A (ja)
KR (1) KR20070116821A (ja)
CN (1) CN101505729A (ja)
AU (1) AU2006223149A1 (ja)
BR (1) BRPI0609012A2 (ja)
CA (1) CA2599464A1 (ja)
MX (1) MX2007011161A (ja)
WO (1) WO2006099276A2 (ja)
ZA (1) ZA200708753B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
US8298565B2 (en) 2005-07-15 2012-10-30 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
PL2019657T3 (pl) 2006-04-26 2015-10-30 Micell Technologies Inc Powłoki zawierające wiele leków
US8636767B2 (en) 2006-10-02 2014-01-28 Micell Technologies, Inc. Surgical sutures having increased strength
CN101678388B (zh) 2006-10-23 2013-12-11 米歇尔技术公司 用于在涂覆过程中为基底充电的保持器
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CA2679712C (en) 2007-01-08 2016-11-15 Micell Technologies, Inc. Stents having biodegradable layers
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
EP2170418B1 (en) 2007-05-25 2016-03-16 Micell Technologies, Inc. Polymer films for medical device coating
MX2010011485A (es) 2008-04-17 2011-03-01 Micell Technologies Inc Stents que contienen capas bioadsorbibles.
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
AU2009270849B2 (en) 2008-07-17 2013-11-21 Micell Technologies, Inc. Drug delivery medical device
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
EP2411440B1 (en) * 2009-03-23 2018-01-17 Micell Technologies, Inc. Improved biodegradable polymers
JP2012522589A (ja) 2009-04-01 2012-09-27 ミシェル テクノロジーズ，インコーポレイテッド 被覆ステント
EP2531140B1 (en) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
EP2560576B1 (en) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (en) 2010-07-16 2022-11-30 Micell Technologies, Inc. Drug delivery medical device
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
CN110269959A (zh) 2013-03-12 2019-09-24 脉胜医疗技术公司 可生物吸收的生物医学植入物
CA2912387C (en) 2013-05-15 2019-04-16 Micell Technologies, Inc. Bioabsorbable biomedical implants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021229A1 (en) * 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6890452B2 (en) * 2002-11-08 2005-05-10 3M Innovative Properties Company Fluorinated surfactants for aqueous acid etch solutions
CA2581575A1 (en) * 2004-09-24 2006-04-06 3M Innovative Properties Company Medicinal aerosol formulations and methods of synthesizing ingredients therefor

Also Published As

Publication number Publication date
CA2599464A1 (en) 2006-09-21
WO2006099276A3 (en) 2009-04-30
KR20070116821A (ko) 2007-12-11
EP1868610A4 (en) 2012-06-06
JP2008533149A (ja) 2008-08-21
EP1868610A2 (en) 2007-12-26
AU2006223149A1 (en) 2006-09-21
US20080112894A1 (en) 2008-05-15
BRPI0609012A2 (pt) 2016-11-29
MX2007011161A (es) 2007-11-13
CN101505729A (zh) 2009-08-12
WO2006099276A2 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
ZA200708753B (en) Biocompatible polymer compounds for medicinal formulations
EP1968493A4 (en) DIFFUSION-CURED MEDICAL IMPLANT
HK1152478A1 (en) Solid pharmaceutical formulations comprising bibw 2992
IL177566A0 (en) Pharmaceutical formulations
EP1796632A4 (en) ORGANOGEL-BASED FORMULATIONS FOR THERAPEUTIC APPLICATIONS
IL180691A0 (en) Organo-gel formulations for therapeutic applications
EP1981547A4 (en) STABLE THERAPEUTIC FORMULATIONS
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
GB0426301D0 (en) Pharmaceutical formulations
PL1957073T3 (pl) Substancja lecznicza
HK1180949A1 (en) Long lasting drug formulations
GB0618930D0 (en) Medical implant
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
IL185197A0 (en) Ophthalmological pharmaceutical compositions
EP1753405A4 (en) SLOW RELEASE PHARMACEUTICAL PREPARATION
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
IL198160A0 (en) Pharmaceutical formulations
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
GB0406048D0 (en) Drug formulations
GB0511841D0 (en) Polymer formulations
AU2005904004A0 (en) Compounds for medicinal treatment
GB0615461D0 (en) Pharmaceutical formulations
GB0408070D0 (en) Pharmaceutical formulations
GB0428010D0 (en) Pharmaceutical formulations